Cash flow Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 16:35:29 08/05/2026 BST			5-day change	1st Jan Change
113.10 ^GBX	-1.99%		-4.07%	-11.92%

04-20	Roadside Real Estate CEO buys after Hoch purchase	AN
04-15	Cepheid and Oxford Nanopore Technologies Expand Partnership for Infectious Disease Research Collaboration	CI

46fdff675be3c5a.7qa04httnO_y7zS115APJeB-yq06DmbXt5E4vxI-Y04.l8vVoHda39qBmFeDgep6XYxLk_pbQxLkgtYI3FwTVD2f3-6waDvThb-wWw

Published financial data: OXFORD NANOPORE TECHNOLOGIES PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	134M	199M	170M	183M	224M
Total Revenues	134M	199M	170M	183M	224M
Cost of Goods Sold, Total	60.47M	74.79M	79.19M	77.8M	87.5M
Gross Profit	73.2M	124M	90.48M	105M	136M
Selling General & Admin Expenses, Total	162M	157M	155M	157M	180M
R&D Expenses	75.98M	64.84M	103M	98.47M	89.4M
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-	-	889K	2.73M	-1.8M
Other Operating Expenses, Total	238M	222M	259M	258M	268M
Operating Income	-165M	-98.48M	-169M	-152M	-131M
Interest Expense, Total	-908K	-1.63M	-2.21M	-3.56M	-2.8M
Interest And Investment Income	224K	5.94M	18.85M	14.84M	11.8M
Net Interest Expenses	-684K	4.31M	16.65M	11.28M	9M
Income (Loss) On Equity Invest.	-64K	-238K	-228K	-18K	-
Currency Exchange Gains (Loss)	504K	-5.43M	2.12M	-151K	-
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-165M	-99.84M	-150M	-141M	-122M
Restructuring Charges	-	-	-	-	-20.8M
Gain (Loss) On Sale Of Investments	-1.23M	-2.19M	297K	1.26M	8.2M
Gain (Loss) On Sale Of Assets	-	18.62M	-	-	-
Asset Writedown	-	-	-	-	-5.1M
EBT, Incl. Unusual Items	-166M	-83.41M	-150M	-140M	-140M
Income Tax Expense	1.61M	7.61M	4.74M	6.23M	5.3M
Earnings From Continuing Operations	-168M	-91.02M	-155M	-146M	-145M
Net Income to Company	-168M	-91.02M	-155M	-146M	-145M
Net Income - (IS)	-168M	-91.02M	-155M	-146M	-145M
Net Income to Common Incl Extra Items	-168M	-91.02M	-155M	-146M	-145M
Net Income to Common Excl. Extra Items	-168M	-91.02M	-155M	-146M	-145M
Per Share Items
Net EPS - Basic	-0.23	-0.11	-0.19	-0.16	-0.15
Basic EPS - Continuing Operations	-0.23	-0.11	-0.19	-0.16	-0.15
Basic Weighted Average Shares Outstanding	732M	824M	834M	898M	961M
Net EPS - Diluted	-0.23	-0.11	-0.19	-0.16	-0.15
Diluted EPS - Continuing Operations	-0.23	-0.11	-0.19	-0.16	-0.15
Diluted Weighted Average Shares Outstanding	732M	824M	834M	898M	961M
Normalized Basic EPS	-0.14	-0.08	-0.11	-0.1	-0.08
Normalized Diluted EPS	-0.14	-0.08	-0.11	-0.1	-0.08
American Depositary Receipts Ratio (ADR)	4	4	4	4	4
Supplemental Items
EBITDA	-152M	-82.46M	-150M	-139M	-116M
EBITA	-164M	-98.43M	-169M	-152M	-131M
EBIT	-165M	-98.48M	-169M	-152M	-131M
EBITDAR	-	-	-150M	-138M	-114M
Effective Tax Rate - (Ratio)	-0.97	-9.13	-3.16	-4.45	-3.79
Total Current Taxes	6.16M	7.92M	4.52M	3.99M	4.1M
Total Deferred Taxes	-4.56M	-310K	214K	2.24M	1.2M
Normalized Net Income	-103M	-62.4M	-93.79M	-88.27M	-76.38M
Interest on Long-Term Debt	908K	1.63M	2.2M	3.56M	2.8M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	75.98M	64.84M	104M	98.92M	97.7M
Net Rental Expense, Total	-	-	928K	971K	1.2M
Imputed Operating Lease Interest Expense	-	-	432K	632K	614K
Imputed Operating Lease Depreciation	-	-	496K	339K	586K
Stock-Based Comp., SG&A Exp. (Total)	-	-	20.89M	-6.15M	200K
Stock-Based Comp., Other (Total)	62.45M	70.01M	14.02M	10.07M	20M
Total Stock-Based Compensation	62.45M	70.01M	34.91M	3.92M	20.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	488M	357M	221M	200M	181M
Short Term Investments	-	119M	49.51M	139M	74.2M
Total Cash And Short Term Investments	488M	476M	270M	338M	255M
Accounts Receivable, Total	38.47M	41.18M	33.83M	37.54M	46.7M
Other Receivables	22.49M	20.2M	28.7M	31.81M	19.9M
Total Receivables	60.97M	61.38M	62.53M	69.35M	66.6M
Inventory	63.07M	87.7M	102M	99.45M	81.5M
Prepaid Expenses	8.1M	10.67M	12.8M	12.92M	16.6M
Other Current Assets, Total	131M	2.06M	261K	-	-
Total Current Assets	751M	638M	447M	520M	420M
Gross Property Plant And Equipment	110M	127M	162M	192M	198M
Accumulated Depreciation	-47.72M	-64.25M	-79.35M	-90.78M	-105M
Net Property Plant And Equipment	61.92M	63.2M	82.42M	101M	92.8M
Long-term Investments	257K	84.97M	209M	74.31M	51.2M
Other Intangibles, Total	396K	30.04M	2.14M	43.82M	55.8M
Deferred Tax Assets Long-Term	6.08M	7.68M	5.49M	2.64M	2.7M
Deferred Charges Long-Term	22.61M	-	30.77M	-	-
Total Assets	842M	824M	777M	742M	622M
Liabilities
Accounts Payable, Total	20.49M	23.1M	25.18M	31.3M	18.4M
Accrued Expenses, Total	55.11M	41.32M	43.87M	54.02M	58.1M
Current Portion of Leases	2.61M	15.05M	4.32M	5.36M	5.2M
Current Income Taxes Payable	4.42M	1.64M	-	-	-
Unearned Revenue Current, Total	21.63M	20.3M	15.16M	20.67M	34.4M
Other Current Liabilities	789K	1.12M	671K	145K	1.9M
Total Current Liabilities	105M	103M	89.2M	111M	118M
Long-Term Debt	9.5M	-	-	-	-
Long-Term Leases	12.69M	19.05M	37.33M	40.61M	36.3M
Other Non Current Liabilities	10.65M	8.75M	6.68M	3.62M	4.9M
Total Liabilities	138M	130M	133M	156M	159M
Common Stock, Total	82K	83K	86K	96K	100K
Additional Paid In Capital	624M	628M	699M	780M	786M
Retained Earnings	-15.9M	-106M	-258M	-402M	-551M
Comprehensive Income and Other	96.04M	172M	203M	209M	228M
Total Common Equity	704M	694M	644M	586M	463M
Total Equity	704M	694M	644M	586M	463M
Total Liabilities And Equity	842M	824M	777M	742M	622M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	822M	826M	859M	955M	966M
ECS Total Common Shares Outstanding	822M	826M	859M	955M	966M
Book Value / Share	0.86	0.84	0.75	0.61	0.48
Tangible Book Value	704M	664M	642M	543M	408M
Tangible Book Value Per Share	0.86	0.8	0.75	0.57	0.42
Total Debt	24.8M	34.1M	41.66M	45.96M	41.5M
Net Debt	-463M	-442M	-228M	-292M	-214M
Debt Equivalent Oper. Leases	-	-	7.42M	7.77M	9.6M
Equity Method Investments, Total	257K	826K	742K	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	25.78M	41.85M	50.89M	37.63M	24.8M
Inventories - Work In Process, Total	17.83M	34.96M	39.15M	45.64M	45.6M
Inventories - Finished Goods, Total	19.46M	10.89M	11.51M	16.18M	11.1M
Land - (BS)	15.06M	-	-	-	-
Machinery, Total	33.32M	38.86M	48M	55.22M	60.9M
Full Time Employees	803	1.01K	1.24K	1.38K	1.32K
Assets on Operating Lease - Gross	30.08M	39.84M	54.76M	62.06M	62.9M
Assets on Operating Lease - Accumulated Depreciation	-15.87M	-23.5M	-27.13M	-27.4M	-31.1M
Accumulated Allowance for Doubtful Accounts (Supple)	2.96M	2.61M	947K	2.08M	3.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-168M	-91.02M	-155M	-146M	-145M
Depreciation & Amortization - CF	15.55M	20.44M	23.14M	19.33M	20.9M
Amortization of Goodwill and Intangible Assets - (CF)	50K	50K	72K	256K	200K
Depreciation & Amortization, Total	15.6M	20.49M	23.21M	19.58M	21.1M
Amortization of Deferred Charges, Total - (CF)	9.09M	11.38M	18.42M	23.7M	28.7M
(Gain) Loss From Sale Of Asset	837K	-16.74M	3.85M	7.51M	3.8M
(Gain) Loss on Sale of Investments - (CF)	1.23M	2.19M	-144K	724K	-
Asset Writedown & Restructuring Costs	-	1.17M	-	-	1.8M
(Income) Loss On Equity Investments - (CF)	64K	238K	228K	18K	-
Stock-Based Compensation (CF)	62.45M	48.78M	34.91M	3.92M	20.4M
Other Operating Activities, Total	7.5M	1.8M	-21.83M	-17.32M	-3.3M
Change In Accounts Receivable	10.89M	-7.4M	118K	-1.82M	-9.4M
Change In Inventories	-27.44M	-24.72M	-43.06M	-21.18M	4.9M
Change In Accounts Payable	33.57M	4.43M	1.5M	21.17M	6.6M
Cash from Operations	-53.83M	-49.39M	-137M	-110M	-70.6M
Capital Expenditure	-21.54M	-23.07M	-5.91M	-13.94M	-3.5M
Sale of Property, Plant, and Equipment	-	42.5M	-	-	-
Sale (Purchase) of Intangible assets	-9.28M	-19.16M	-21.38M	-34.69M	-42.2M
Investment in Marketable and Equity Securities, Total	-131M	-69.5M	-48.4M	54.16M	94.2M
Other Investing Activities, Total	207K	3.44M	13.9M	9.51M	7.8M
Cash from Investing	-162M	-65.79M	-61.79M	15.03M	56.3M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.36M	-13.61M	-4.29M	-4.68M	-5.8M
Total Debt Repaid	-2.36M	-13.61M	-4.29M	-4.68M	-5.8M
Issuance of Common Stock	642M	3.75M	71.6M	83.23M	6.7M
Other Financing Activities, Total	-16.88M	-3.86M	-2.57M	-4.97M	-3M
Cash from Financing	623M	-13.72M	64.73M	73.58M	-2.1M
Foreign Exchange Rate Adjustments	-117K	-2.17M	-1.88M	258K	-2M
Net Change in Cash	407M	-131M	-136M	-21.02M	-18.4M
Supplemental Items
Cash Interest Paid	949K	1.48M	2.21M	2.64M	2.9M
Cash Income Tax Paid (Refund)	-8.8M	-1.23M	417K	-4.21M	-18.9M
Levered Free Cash Flow	-155M	-47.54M	-75.44M	-82.2M	-35.65M
Unlevered Free Cash Flow	-155M	-46.53M	-74.06M	-79.98M	-33.9M
Change In Net Working Capital	108M	44.62M	17.93M	-16.66M	-23.8M
Net Debt Issued / Repaid	-2.36M	-13.61M	-4.29M	-4.68M	-5.8M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-18.31	-7.39	-13.16	-12.53	-12.02
Return on Total Capital	-21.92	-8.45	-14.91	-14.45	-14.42
Return On Equity %	-37.67	-13.03	-23.11	-23.77	-27.67
Return on Common Equity	-37.67	-13.03	-23.11	-23.77	-27.67
Margin Analysis
Gross Profit Margin %	54.76	62.34	53.33	57.53	60.92
SG&A Margin	121.02	79.28	91.33	85.45	80.39
EBITDA Margin %	-113.42	-41.52	-88.66	-75.67	-51.63
EBITA Margin %	-123.06	-49.56	-99.33	-83.02	-58.51
EBIT Margin %	-123.1	-49.59	-99.38	-83.16	-58.6
Income From Continuing Operations Margin %	-125.4	-45.83	-91.06	-79.8	-64.85
Net Income Margin %	-125.4	-45.83	-91.06	-79.8	-64.85
Net Avail. For Common Margin %	-125.4	-45.83	-91.06	-79.8	-64.85
Normalized Net Income Margin	-77.05	-31.42	-55.28	-48.18	-34.11
Levered Free Cash Flow Margin	-116.16	-23.94	-44.46	-44.87	-15.92
Unlevered Free Cash Flow Margin	-115.74	-23.43	-43.65	-43.66	-15.14
Asset Turnover
Asset Turnover	0.24	0.24	0.21	0.24	0.33
Fixed Assets Turnover	2.32	3.17	2.33	2	2.31
Receivables Turnover (Average Receivables)	2.99	4.99	4.52	5.13	5.31
Inventory Turnover (Average Inventory)	1.23	0.99	0.84	0.77	0.97
Short Term Liquidity
Current Ratio	7.15	6.22	5.01	4.66	3.56
Quick Ratio	5.22	5.24	3.73	3.66	2.73
Operating Cash Flow to Current Liabilities	-0.51	-0.48	-1.54	-0.99	-0.6
Days Sales Outstanding (Average Receivables)	122.02	73.2	80.68	71.29	68.71
Days Outstanding Inventory (Average Inventory)	297.89	367.89	436.15	472.82	377.51
Average Days Payable Outstanding	106.9	80.01	94.72	136.54	130.51
Cash Conversion Cycle (Average Days)	313.01	361.07	422.11	407.56	315.72
Long Term Solvency
Total Debt/Equity	3.52	4.92	6.47	7.84	8.96
Total Debt / Total Capital	3.4	4.69	6.08	7.27	8.22
LT Debt/Equity	3.15	2.75	5.8	6.93	7.84
Long-Term Debt / Total Capital	3.05	2.62	5.45	6.42	7.19
Total Liabilities / Total Assets	16.38	15.82	17.14	20.98	25.57
EBIT / Interest Expense	-181.2	-60.49	-76.43	-42.73	-46.86
EBITDA / Interest Expense	-164.03	-47.9	-65.91	-37.24	-39.32
(EBITDA - Capex) / Interest Expense	-187.74	-62.07	-68.59	-41.15	-40.57
Total Debt / EBITDA	-0.17	-0.44	-0.29	-0.35	-0.38
Net Debt / EBITDA	3.11	5.67	1.57	2.2	1.94
Total Debt / (EBITDA - Capex)	-0.15	-0.34	-0.28	-0.31	-0.37
Net Debt / (EBITDA - Capex)	2.72	4.37	1.51	1.99	1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.39	48.59	-14.57	7.97	22.22
Gross Profit, 1 Yr. Growth %	56.14	69.15	-26.92	16.48	29.41
EBITDA, 1 Yr. Growth %	140.87	-45.6	82.43	-7.85	-16.59
EBITA, 1 Yr. Growth %	125.13	-40.16	71.23	-9.77	-13.87
EBIT, 1 Yr. Growth %	125.2	-40.15	71.21	-9.65	-13.85
Earnings From Cont. Operations, 1 Yr. Growth %	173.68	-45.69	69.74	-5.38	-0.68
Net Income, 1 Yr. Growth %	173.68	-45.69	69.74	-5.38	-0.68
Normalized Net Income, 1 Yr. Growth %	125.25	-39.41	50.31	-5.89	-13.52
Diluted EPS Before Extra, 1 Yr. Growth %	163.73	-51.75	67.66	-12.11	-7.22
Accounts Receivable, 1 Yr. Growth %	-24.41	7.04	-17.85	10.96	24.2
Inventory, 1 Yr. Growth %	77.03	39.05	15.79	-2.06	-18.09
Net Property, Plant and Equip., 1 Yr. Growth %	16.39	2.07	30.4	22.78	-8.3
Total Assets, 1 Yr. Growth %	199.37	-2.14	-5.68	-4.51	-16.11
Tangible Book Value, 1 Yr. Growth %	279.31	-2.56	-7.43	-11.2	-24.88
Common Equity, 1 Yr. Growth %	278.62	-1.48	-7.17	-8.93	-20.98
Cash From Operations, 1 Yr. Growth %	-15.64	-7.17	115.12	-19.97	-35.76
Capital Expenditures, 1 Yr. Growth %	36.85	7.13	-31.58	136.08	-74.82
Levered Free Cash Flow, 1 Yr. Growth %	254.08	93.01	38.86	8.96	-55.59
Unlevered Free Cash Flow, 1 Yr. Growth %	256.58	93.33	38.93	7.98	-56.56
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	60.23	32.07	12.67	-3.96	14.88
Gross Profit, 2 Yr. CAGR %	69.03	62.51	11.18	-7.74	22.78
EBITDA, 2 Yr. CAGR %	47.4	14.47	-0.38	29.66	-12.34
EBITA, 2 Yr. CAGR %	42.6	16.07	1.22	24.3	-11.84
EBIT, 2 Yr. CAGR %	42.62	16.1	1.23	24.37	-11.79
Earnings From Cont. Operations, 2 Yr. CAGR %	52.35	21.91	-3.99	26.73	-3.06
Net Income, 2 Yr. CAGR %	52.35	21.91	-3.99	26.73	-3.06
Normalized Net Income, 2 Yr. CAGR %	43.08	16.82	-4.57	18.93	-9.76
Diluted EPS Before Extra, 2 Yr. CAGR %	35.83	12.81	-10.05	21.39	-9.69
Accounts Receivable, 2 Yr. CAGR %	65.03	-10.05	-6.23	-4.53	17.49
Inventory, 2 Yr. CAGR %	77.43	56.89	26.89	6.49	-10.41
Net Property, Plant and Equip., 2 Yr. CAGR %	19.51	8.99	15.37	26.53	6.11
Total Assets, 2 Yr. CAGR %	126.06	71.17	-3.93	-5.1	-10.5
Tangible Book Value, 2 Yr. CAGR %	153.45	89.13	-2.93	-11.53	-18.33
Common Equity, 2 Yr. CAGR %	153.52	93.14	-4.37	-8.05	-15.17
Cash From Operations, 2 Yr. CAGR %	5.15	-12.02	60.64	31.21	-28.29
Capital Expenditures, 2 Yr. CAGR %	8	21.08	-47.63	27.09	-23.02
Levered Free Cash Flow, 2 Yr. CAGR %	34.37	4.13	75.01	23.01	-31.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	34.42	3.56	75.43	22.48	-32.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	60.18	56.25	14.22	11.08	4.08
Gross Profit, 3 Yr. CAGR %	65.95	69.07	24.51	12.92	3.28
EBITDA, 3 Yr. CAGR %	38.87	5.73	33.71	-2.94	11.92
EBITA, 3 Yr. CAGR %	37.88	6.76	32.13	-2.58	10
EBIT, 3 Yr. CAGR %	37.9	6.78	32.15	-2.54	10.03
Earnings From Cont. Operations, 3 Yr. CAGR %	46.67	8.02	36.13	-4.46	16.84
Net Income, 3 Yr. CAGR %	46.67	8.02	36.13	-4.46	16.84
Normalized Net Income, 3 Yr. CAGR %	38.5	7.45	27.06	-5.01	6.97
Diluted EPS Before Extra, 3 Yr. CAGR %	35.93	-3.8	28.74	-10.74	10.99
Accounts Receivable, 3 Yr. CAGR %	49.24	42.85	-12.73	-0.82	4.28
Inventory, 3 Yr. CAGR %	50.23	63.58	41.79	16.39	-2.41
Net Property, Plant and Equip., 3 Yr. CAGR %	32.76	13.39	15.71	17.79	13.66
Total Assets, 3 Yr. CAGR %	68.75	71.01	40.33	-4.12	-8.92
Tangible Book Value, 3 Yr. CAGR %	70.12	82.3	51.24	-7.3	-16.23
Common Equity, 3 Yr. CAGR %	70.16	85.01	51.29	-5.91	-12.58
Cash From Operations, 3 Yr. CAGR %	-1.36	0.48	29.1	27.35	3.42
Capital Expenditures, 3 Yr. CAGR %	24.41	7.71	-27.87	-13.49	-25.99
Levered Free Cash Flow, 3 Yr. CAGR %	37.49	-17.93	19.83	49.44	-13.1
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.53	-18.4	19.52	49.23	-14.01
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	96.79	70.49	39.15	28.61	14.48
Gross Profit, 5 Yr. CAGR %	157.62	79.06	41.39	32.69	23.81
EBITDA, 5 Yr. CAGR %	18.97	5.17	21.59	14.72	12.93
EBITA, 5 Yr. CAGR %	20.42	8.36	21.85	13.46	12.39
EBIT, 5 Yr. CAGR %	20.43	8.37	21.86	13.5	12.42
Earnings From Cont. Operations, 5 Yr. CAGR %	23.18	9.99	23.81	15.15	18.84
Net Income, 5 Yr. CAGR %	23.18	9.99	23.81	15.15	18.84
Normalized Net Income, 5 Yr. CAGR %	20.56	8.67	19.33	11.9	10.81
Diluted EPS Before Extra, 5 Yr. CAGR %	15.88	1.13	15.23	5.58	11.72
Accounts Receivable, 5 Yr. CAGR %	94.28	55.74	23.92	21.59	-1.71
Inventory, 5 Yr. CAGR %	184.23	68.54	40.42	37.77	18
Net Property, Plant and Equip., 5 Yr. CAGR %	77.93	24.21	25.51	18.47	11.77
Total Assets, 5 Yr. CAGR %	39.57	47.18	34.71	35.12	17.23
Tangible Book Value, 5 Yr. CAGR %	37.29	47.96	35.04	37.71	17.05
Common Equity, 5 Yr. CAGR %	37.31	49.27	35.13	39.87	20.03
Cash From Operations, 5 Yr. CAGR %	1	-5.73	19.61	17.68	2.04
Capital Expenditures, 5 Yr. CAGR %	48.01	3.18	-11.99	-5.46	-25.97
Levered Free Cash Flow, 5 Yr. CAGR %	22.91	-1.25	4.78	-0.9	-4.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.82	-1.67	4.49	-1.35	-4.81